Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Aurinia Pharm Ord
(NQ:
AUPH
)
5.760
-0.010 (-0.17%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Aurinia Pharm Ord
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Financial Stocks: WFC, MS, C, BAC, JPM and GS Gain on Powell Fed Chairman’s Second Term
November 22, 2021
Financial stocks are doing well on Monday thanks to an update from the U.S. Government concerning the next Federal Reserve chairman.
Via
InvestorPlace
Topics
Economy
Exposures
Interest Rates
AUPH Stock: 13 Things to Know About Aurinia Pharma as Shares Crash Today
November 22, 2021
Aurinia Pharma (AUPH) stock is taking a beating on Monday following a filing with the SEC after markets closed on Friday.
Via
InvestorPlace
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Mid-Day Market Update: Gold Down 2%; iSpecimen Shares Spike Higher
November 22, 2021
Midway through trading Monday, the Dow traded up 0.65% to 35,832.70 while the NASDAQ rose 0.67% to 16,164.51. The S&P also rose, gaining 0.87% to 4,738.91. The U.S. has the...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
40 Stocks Moving In Monday's Mid-Day Session
November 22, 2021
Gainers iSpecimen Inc. (NASDAQ: ISPC) shares climbed 126.5% to $11.12 after the company announced it has been contracted to support new advanced research on COVID-19 seeking...
Via
Benzinga
Exposures
COVID-19
Here's Why Aurinia Pharmaceuticals Is Falling Today
November 22, 2021
The company's recently filed unlimited shelf registration statement is making shareholders queasy.
Via
The Motley Fool
Mid-Morning Market Update: Markets Open Higher; Avaya Tops Q4 Views
November 22, 2021
Following the market opening Monday, the Dow traded up 0.77% to 35,876.58 while the NASDAQ rose 0.91% to 16,203.01. The S&P also rose, gaining 0.91% to 4,740.94. The U.S. has...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
November 22, 2021
Welcome back, traders! We're getting right into the week with a breakdown of the biggest pre-market stock movers for Monday!
Via
InvestorPlace
Exposures
Product Safety
20 Stocks Moving in Monday's Pre-Market Session
November 22, 2021
Gainers Astra Space, Inc. (NASDAQ: ASTR) rose 39.6% to $13.30 in pre-market trading after declining around 3% on Friday. Astra Space recently reported a Q3 loss of $0.06 per...
Via
Benzinga
Why Aurinia Pharmaceuticals Stock Crashed in After-Hours Trading on Friday
November 20, 2021
A $250 mixed shelf offering isn't sitting well with the biotech's shareholders.
Via
The Motley Fool
Aurinia Pharmaceuticals to Present at the 2021 Jefferies London Healthcare Conference
November 10, 2021
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Is Bristol Myers Squibb's Reported Acquisition of Aurinia a Smart Move?
November 06, 2021
It could be.
Via
The Motley Fool
What 5 Analyst Ratings Have To Say About Aurinia Pharmaceuticals
November 04, 2021
Over the past 3 months, 5 analysts have published their opinion on Aurinia Pharmaceuticals (NASDAQ:
Via
Benzinga
Aurinia Pharmaceuticals Inc (AUPH) Q3 2021 Earnings Call Transcript
November 03, 2021
AUPH earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Here's Why Bristol Myers Squibb Can't Miss Out on Aurinia Pharmaceuticals
November 03, 2021
The biopharma's takeover bid has failed to materialize after nearly two weeks. Here's what might be going on.
Via
The Motley Fool
Aurinia Pharmaceuticals: Q3 Earnings Insights
November 03, 2021
Aurinia Pharmaceuticals (NASDAQ:AUPH) reported its Q3 earnings results on Wednesday, November 3, 2021 at 08:00 AM. Here's what investors need to know about the...
Via
Benzinga
Aurinia Reports Third Quarter and Nine Months 2021 Financial Results and Company Updates
November 03, 2021
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Aurinia Announces Updated Interim Results from the AURORA 2 Continuation Study of LUPKYNIS (voclosporin) for the Treatment of Lupus Nephritis
November 01, 2021
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
No Negative Reaction
October 28, 2021
Today the impact of the Delta variant hit US GDP which was only 2% annualized, vs estimates of 2.6%, based on Q3 data which came out today.
Via
Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For October 28, 2021
October 28, 2021
Upgrades For Boot Barn Holdings Inc (NYSE:
Via
Benzinga
Aurinia Pharmaceuticals to Release Third Quarter 2021 Financial Results on November 3, 2021
October 27, 2021
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Aurinia Pharmaceuticals to Present Five Abstracts at ASN Kidney Week 2021 and ACR Convergence 2021
October 26, 2021
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Cyber Currency
October 26, 2021
Canadian stocks are particularly buoyant and not just in energy which is a riser today because the loony is up against the buck.
Via
Talk Markets
Aurinia Rockets — Again — On Rumored Bristol Marriage; Could Others Make A Pass?
October 25, 2021
Aurinia stock hit another record Monday on Bristol's rumored takeover.
Via
Investor's Business Daily
55 Biggest Movers From Friday
October 25, 2021
Gainers Phunware, Inc. (NASDAQ: PHUN) shares jumped 471.2% to close at $8.74 on Friday. Phunware shares jumped over 45% on Thursday, possibly in sympathy with Digital World...
Via
Benzinga
Why Aurinia Pharmaceuticals Stock Is Blasting Higher Today
October 22, 2021
The biotech is reportedly in buyout talks with Bristol Myers Squibb.
Via
The Motley Fool
Aurinia Pharma Stock Pops On Reports Of Looming Bristol Myers Takeover
October 22, 2021
Bristol is reportedly interested in acquiring Aurinia, according to reports that sent AUPH stock flying before it was halted.
Via
Investor's Business Daily
More Chinese Trouble
October 14, 2021
A day after the consumer price rise there was another price rise for producer markets.
Via
Talk Markets
A Bit Of A Recovery
September 29, 2021
While Germany remains without a government, Japan has a new prime minister who will lead his party in the election this week.
Via
Talk Markets
Pharma, Tech and Finance
September 20, 2021
Good news on some drugs was not enough to boost stock markets.
Via
Talk Markets
The Daily Biotech Pulse: Pfizer-BioNTech US Vaccine Contract, Summit Slumps On Adverse Regulatory Feedback, Cerevel CFO Departs
September 22, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 20) Acceleron Pharma Inc. (...
Via
Benzinga
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.